MRI After Radiosurgery for Brain Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to test whether an additional magnetic resonance image (MRI) sequence can improve the ability to distinguish radiation damage from tumor recurrence in participants with brain metastasis who have previously been treated with stereotactic radiosurgery (SRS).
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is MRI safe for humans after radiosurgery for brain cancer?
How does MRI after radiosurgery for brain cancer differ from other treatments?
This treatment is unique because it uses MRI after stereotactic radiosurgery (a precise form of radiation therapy) to monitor brain cancer, helping to distinguish between tumor regrowth and radiation-induced changes. This approach enhances diagnostic accuracy and aids in decision-making for further treatment.23678
What data supports the effectiveness of the treatment MRI after radiosurgery for brain cancer?
Who Is on the Research Team?
Scott Floyd, MD PhD
Principal Investigator
Duke Health
Are You a Good Fit for This Trial?
This trial is for adults over 18 with brain metastasis from solid tumors, excluding small cell lung cancer and lymphoma, who've had stereotactic radiosurgery (SRS). They must be candidates for brain surgery, able to undergo MRI with contrast, and have signed an informed consent.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Radiation
Participants undergo stereotactic radiosurgery (SRS) for brain metastases
MRI Evaluation
Participants receive additional MRI sequences to distinguish radiation damage from tumor recurrence
Follow-up
Participants are monitored for safety and effectiveness after MRI evaluation
What Are the Treatments Tested in This Trial?
Interventions
- MRI
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor